Maternal Folic Acid, Multivitamin Use May Cut ASD Risk in Offspring

Share this content:
Maternal Folic Acid, Multivitamin Use May Cut ASD Risk in Offspring
Maternal Folic Acid, Multivitamin Use May Cut ASD Risk in Offspring

MONDAY, Jan. 8, 2018 (HealthDay News) -- The risk of autism spectrum disorder (ASD) is reduced in offspring with maternal exposure to folic acid and multivitamin supplementation before and during pregnancy, according to a study published online Jan. 3 in JAMA Psychiatry.

Stephen Z. Levine, Ph.D., from the University of Haifa in Israel, and colleagues conducted a case-control cohort study involving 45,300 Israeli children born between Jan. 1, 2003, and Dec. 31, 2007, who were followed for ASD from birth to Jan. 26, 2015.

The researchers found that 1.3 percent of the 45,300 children in the study received a diagnosis of ASD. There was a statistically significant association for maternal exposure to folic acid and/or multivitamin supplements before pregnancy with reduced likelihood of ASD in offspring compared with no exposure before pregnancy (relative risk, 0.39). Compared with no exposure during pregnancy, maternal exposure to folic acid and/or multivitamins during pregnancy was associated with lower likelihood of ASD in offspring (relative risk, 0.27). The relative risks were 0.56, 0.32, 0.36, and 0.35 for maternal exposure to folic acid before and during pregnancy and for maternal exposure to multivitamin supplements before and during pregnancy, respectively.

"Maternal exposure to folic acid and multivitamin supplements before and during pregnancy is associated with a reduced risk of ASD in the offspring compared with the offspring of mothers without such exposure," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

Study Finds 31 Percent Use No Opioids After Surgery

Study Finds 31 Percent Use No Opioids After ...

At discharge, 92.2 percent of patients received an opioid prescription; nearly 63 percent unused

PAs May Have Lower Diagnostic Accuracy for Melanoma

PAs May Have Lower Diagnostic Accuracy for Melanoma

PAs diagnose fewer melanomas in situ, perform more skin biopsies per case of skin cancer diagnosed

AAN: Neuromodulation Therapy Gives Relief From Hand Tremor

AAN: Neuromodulation Therapy Gives Relief From Hand Tremor

Non-invasive neuromodulation therapy using a custom stimulation pattern safe for essential tremor

is free, fast, and customized just for you!

Already a member?

Sign In Now »